Cargando…

Inhaled Bronchodilator Use for Infants with Bronchopulmonary Dysplasia

OBJECTIVE: To identify factors associated with bronchodilator administration to infants with bronchopulmonary dysplasia (BPD) and evaluate inter-institutional prescribing patterns. STUDY DESIGN: A retrospective cohort study of <29-week-gestation infants with evolving BPD defined at age 28 days wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Slaughter, Jonathan L, Stenger, Michael R, Reagan, Patricia B, Jadcherla, Sudarshan R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281278/ https://www.ncbi.nlm.nih.gov/pubmed/25102319 http://dx.doi.org/10.1038/jp.2014.141

Ejemplares similares

Utilization of Inhaled Corticosteroids for Infants with Bronchopulmonary Dysplasia
por: Slaughter, Jonathan L., et al.
Publicado: (2014)

Systematic Review of Inhaled Bronchodilator and Corticosteroid Therapies in Infants with Bronchopulmonary Dysplasia: Implications and Future Directions
por: Clouse, Brian J., et al.
Publicado: (2016)

Bronchodilator responsiveness and dysanapsis in bronchopulmonary dysplasia
por: Nelin, Leif D., et al.
Publicado: (2022)

Inhaled bronchodilator exposure in the management of bronchopulmonary dysplasia in hospitalized infants
por: Euteneuer, Joshua C., et al.
Publicado: (2020)

Use of Inhaled Iloprost in an Infant With Bronchopulmonary Dysplasia and Pulmonary Artery Hypertension
por: Hwang, Seung-Kyung, et al.
Publicado: (2009)

Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
por: Rivera, Lidys, et al.
Publicado: (2016)

Inhaled nitric oxide in premature infants for preventing bronchopulmonary dysplasia: a meta-analysis
por: Zheng, Yi, et al.
Publicado: (2023)

Pulmonary hypertension in infants with bronchopulmonary dysplasia
por: Kim, Gi Beom
Publicado: (2010)

Inhaled nitric oxide for a severe respiratory syncytial virus infection in an infant with bronchopulmonary dysplasia
por: Leclerc, F., et al.
Publicado: (1994)

Vitamin D and bronchopulmonary dysplasia in preterm infants
por: Joung, K E, et al.
Publicado: (2016)

Association of the Respiratory Severity Score with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension in Infants Born Extremely Preterm
por: Kielt, Matthew, et al.
Publicado: (2023)

Use of inhaled corticosteroids for the prevention and/or treatment of bronchopulmonary dysplasia in preterm infants: a systematic review protocol
por: Shinwell, Eric S., et al.
Publicado: (2015)

Disease Phenotyping of Infants with Severe Bronchopulmonary Dysplasia
por: Mandell, Erica, et al.
Publicado: (2020)

Circulating Endothelial Progenitor Cells Decrease in Infants with Bronchopulmonary Dysplasia and Increase after Inhaled Nitric Oxide
por: Qi, Yuanyuan, et al.
Publicado: (2013)

Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia
por: An, Hyo Soon, et al.
Publicado: (2010)

Nutrition of preterm infants in relation to bronchopulmonary dysplasia
por: Wemhöner, Andreas, et al.
Publicado: (2011)

Cardiovascular morbidity and the use of inhaled bronchodilators
por: Macie, Christine, et al.
Publicado: (2008)

An Innovative Model of Bronchopulmonary Dysplasia in Premature Infants
por: Zhang, Xiaoyue, et al.
Publicado: (2020)

Biomarkers associated with bronchopulmonary dysplasia/mortality in premature infants
por: Balena-Borneman, Jessica, et al.
Publicado: (2016)

Evidence for the Management of Bronchopulmonary Dysplasia in Very Preterm Infants
por: Muehlbacher, Tobias, et al.
Publicado: (2021)

The Pandemic Allocation of Ventilators Model Penalizes Infants with Bronchopulmonary Dysplasia
por: Sundaram, Anupama, et al.
Publicado: (2023)

Utility of echocardiography in predicting mortality in infants with severe bronchopulmonary dysplasia
por: Vyas-Read, Shilpa, et al.
Publicado: (2019)

Modulation of pulmonary desmosomes by inhaler therapy in preterm-born children with bronchopulmonary dysplasia
por: Course, Christopher W., et al.
Publicado: (2023)

Association between anemia and bronchopulmonary dysplasia in preterm infants
por: Duan, Jun, et al.
Publicado: (2016)

In-hospital Outcomes of Premature Infants with Severe Bronchopulmonary Dysplasia
por: Jackson, Wesley, et al.
Publicado: (2017)

Association between probiotics and bronchopulmonary dysplasia in preterm infants
por: Qu, Yangming, et al.
Publicado: (2021)

The nasal microbiome of predicting bronchopulmonary dysplasia in preterm infants
por: Xu, Yanping, et al.
Publicado: (2022)

Efficacy of Sildenafil in Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension
por: Dillon, Kacie, et al.
Publicado: (2023)

Initial respiratory management in preterm infants and bronchopulmonary dysplasia
por: López, Ester Sanz, et al.
Publicado: (2011)

Risk Factors for Tracheobronchomalacia in Preterm Infants With Bronchopulmonary Dysplasia
por: Su, Ya-Ting, et al.
Publicado: (2021)

Respiratory Tract Microecology and Bronchopulmonary Dysplasia in Preterm Infants
por: Sun, Tong, et al.
Publicado: (2021)

Tracheostomy in infants with severe bronchopulmonary dysplasia: A review
por: Akangire, Gangaram, et al.
Publicado: (2023)

NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020)

Timing of Postnatal Steroids for Bronchopulmonary Dysplasia: Association with Pulmonary and Neurodevelopmental Outcomes
por: Harmon, Heidi M., et al.
Publicado: (2020)

Postnatal steroid management in preterm infants with evolving bronchopulmonary dysplasia
por: Htun, Zeyar T., et al.
Publicado: (2021)

Interleukin-4 and 13 concentrations in infants at risk to develop Bronchopulmonary Dysplasia
por: Baier, R John, et al.
Publicado: (2003)

Prediction of Bronchopulmonary Dysplasia in Preterm Infants Using Postnatal Risk Factors
por: Ding, Li, et al.
Publicado: (2020)

Invasive mechanical ventilation and biomarkers as predictors of bronchopulmonary dysplasia in preterm infants
por: Nascimento, Camila Piqui, et al.
Publicado: (2020)

Relevance of clinical features in the prognosis of bronchopulmonary dysplasia in premature infants
por: Du, Zhifang, et al.
Publicado: (2017)

Hydrocortisone and bronchopulmonary dysplasia: variables associated with response in premature infants
por: Clauss, Christie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5d67kel2sdcg4n45ngio2e9jm1